<DOC>
	<DOCNO>NCT00758407</DOCNO>
	<brief_summary>The purpose randomize controlled clinical trial investigate efficacy safety methylphenidate patient fatigue caused cancer .</brief_summary>
	<brief_title>Methylphenidate Treatment Cancer-Related Fatigue</brief_title>
	<detailed_description />
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>history Cancer MFI &gt; 40 Karnofsky Index &gt; =70 outpatient patient able give inform consent treatment psychostimulants past two week screen active tumor disease depression ( HADS &gt; 10 ) cachexia ( BMI &lt; 18kg/m2 ) clinically relevant kidney disorder clinically relevant liver disorder pathological ECGfinding high blood pressure occlusive arterial disease angina pectoris cardiac arrhythmia CHD post heartattack status post stroke status know elevate intraocular pressure know enlarged prostate latent manifest hyperthyreosis alcohol , medication drug dependency past six month manifest drug abuse participation clinical study within past 30 day participation study earlier point time simultaneous participation another clinical trial woman childbearing age without adequate contraception ( contraceptive , intrauterine device , sexual intercourse ) pregnancy ( positive pregnancy test ) lactation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Fatigue , Cancer , Methylphenidate ,</keyword>
</DOC>